Synthesis of glycoconjugate vaccines against Shigella dysenteriae type 1

Journal of Organic Chemistry

Volumn 63, Issue 17, 1998, Pages 5983-5999

  Pozsgay, Vince ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOCONJUGATE; VACCINE;

ANTIBODY RESPONSE; ARTICLE; GLYCOSYLATION; IMMUNOGENICITY; PROTON NUCLEAR MAGNETIC RESONANCE; SHIGELLA DYSENTERIAE; SYNTHESIS;

EID: 0032555442     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo980660a     Document Type: Article

References (90)

1. Jennings, H. J. Curr. Top. Microbiol. Immunol. 1990, 150, 97.
2. Preston, A.; Mandrell, R. E.; Gibson, B. W.; Apicella, M. A. Crit. Rev. Microbiol. 1996, 22, 139.
3. Zähringer, U.; Lindner, B.; Rietschel, E. Th. Adv. Carbohydr. Chem. Biochem. 1994, 50, 211.
4. Francis, T., Jr.; Tillet, W. S. J. Exp. Med. 1930, 52, 573.
5. MacLead, C. M.; Hodges, R. G.; Heidelberger, M.; Bernhard, W. G. J. Exp. Med. 1945, 82, 445.
6. Robbins, J. B.; Immunochemistry 1978, 15, 839.
7. The commercial vaccines [Pneumovax 23, (MSD) and Pnu-Immune (Lederle-Praxis)] contain 25 μg of highly purified capsular polysaccharides of each of the 23 most invasive pneumococci.
8. Mitchell, T. J.; Andrew, P. W.; Molecular and clinical aspects of bacterial vaccine development (Eds.: Ala'alden, D. A. A.; Hormaeche, C. E.) John Wiley & Sons: 1995, p 93.
9. Heidelberger, M.; Dilapi, M. M.; Siegel, M.; Walter, A. W.; J. Immunol. 1950, 65, 535.
10. (a) Egan, W. Ann. Rep. Med. Chem. 1993, 28, 257.
11. (b) Stein, K. E. Int. J. Technol. Ass. Health Care 1994, 10, 167.
12. An exception is the CPS of Group A Neisseria meningitidis that induces protective antibody levels at all ages including infants: Robbins, J. B.; Schneerson, R.; Gotschlich, E. C. Lancet 1997, 350, 1709.
13. Goebel, W. F.; Avery, O. T. J. Exp. Med 1929, 50, 521.
14. Peeters, C. C. A. M.; Lagerman, P. R.; de Weers, O.; Oomen, L. A.; Hoogerhout, P.; Beurret, M.; Poolman, J. T. Vaccine Protocols; Robinson, A., Farrar, G., Wiblin, C., Eds.; Humana Press Inc.: 1996; p 111.
15. Representative examples: (a) Chong, P. L.; Chan, N.; Kandil, A.; Tripet, B.; James, O.; Yang, Y. P.; Shi, S. P.; Klein, M. Infect. Immun. 1997, 65, 4918.
16. (b) Alonso de Velasco, E.; Merkus, D.; Anderton, S.; Verheul, A. F. M.; Lizzio, E. F.; Van der Zee, R.; Van Eden, W.; Hoffmann, T.; Verhoef, J.; Snippe, H. Infect. Immun. 1995, 63, 961.
17. (c) Lett, E.; Gangloff, S.; Zimmermann, M.; Wachsmann, D.; Klein, J.-P. Infect. Immun. 1994, 62, 785.
18. (d) Paradiso, P. R.; Dermody, K.; Pillai, S. Vaccine Res. 1993, 2, 239.
19. (e) Harding, C. V.; Kihlberg, J.; Elofsson, M.; Magnusson, G.; Unanue, E. R.; J. Immunol. 1993, 151, 2419.
20. (f) Ishioka, G. Y.; Lamont, A. G.; Thompson, D.; Bulbow, F.; Gaeta, F. C. A.; Sette, A.; Grey, H. M. J. Immunol. 1992, 148, 2446.
21. Schneerson, R.; Barrera, O.; Sutton, A.; Robbins, J. B. J. Exp. Med. 1980, 152, 361.
22. Commercial conjugate vaccines against Haemophilus influenzae type b: ProHiBit (Connaught), HibTITER (Lederle-Praxis), PedvaxHIB (MSD), ActHIB (Merieux/Connaught).
23. Robbins, J. B.; Schneerson, R.; Anderson, P.; Smith, D. H. J. Am. Med. Assoc. 1996, 276, 1181.
24. Klein, D. L.; Ellis, R. W. New Generation Vaccines; Levine, M. M., Woodrow, G. C., Kaper, J. B., Cobon, G. S., Eds.; Marcel Dekker: 1997; p 503.
25. Robbins, J. B.; Schneerson, R.; Szu, S.; Pozsgay, V. Vaccinia, vaccination and vaccinology: Jenner, Pasteur and their successors; Plotkin, S., Fantini, B., Eds.; Elsevier: 1996; p 135.
26. Svenson, S. B.; Lindberg, A. A. Infect. Immun. 1981, 32, 490.
27. Robbins, J. B.; Schneerson, R.; Szu, S. C. New Generation Vaccines; Levine, M. M., Woodrow, G. C., Kaper, J. B., Cobon, G. S., Eds.; Marcel Dekker: 1997; p 803.
28. Dick, W. E., Jr.; Beurret, M. Contrib. Microbiol. Immunol. 1989, 10, 48.
29. In an exceptional case, a protein conjugate of a disaccharide corresponding to only one repeating unit of type 3 pneumococcus provided protection in adult rabbits: Goebel, W. F. J. Exp. Med. 1940, 72, 33.
30. Svenson, S. B.; Lindberg, A. A. Prog. Allergy 1983, 33, 120.
31. Chu, C.; Liu, B.; Watson, D.; Szu, S.; Bryla, D.; Shiloach, J.; Schneerson, R.; Robbins, J. B. Infect. Immun. 1991, 59, 4450.
32. Howson, C. P.; Fineberg, H. V.; Bloom, B. R. Lancet 1998, 351, 586.
33. Dmitriev, B. A.; Knirel, Y. A.; Kochetkov, N. K.; Hofman, I. Eur. J. Biochem. 1976, 66, 559.
34. Taylor, D. N.; Trofa, A. C.; Sadoff, J.; Chu, C.; Bryla, D.; Shiloach, J.; Cohen, D.; Ashkenazi, S.; Lerman, Y.; Egan, W.; Schneerson, R.; Robbins, J. B. Infect. Immun. 1993, 61, 3678.
35. Some of these studies were reported in a communication: Pozsgay, V. Angew. Chem., Int. Ed. Engl. 1998, 37, 138.
36. The term "oligosaccharide" is used to denote the saccharides synthesized in this work, while cognizant of the fact that by definition (Joint Commission on Biological Nomenclature, Eur. J. Biochem. 1982, 126, 433) oligosaccharides contain up to and including 10 monosaccharide units.
37. For related studies, see: (a) Alamino-Pérez, M.; Quintero, O.; Ortega, P. J. C.; Alvarez, J. A. C.; Roy, R.; Gonzales, G. S.; Verez Bencomo, V. Abstracts, 9th European Carbohydrate Symp.; Utrecht, 1997; A87.
38. (b) Brade, H.; Brabetz, W.; Brade, L.; Holst, O.; Löbau, S.; Lukacova, M.; Mamat, U.; Rozalski, A.; Zych, K.; Kosma, P. Pure Appl. Chem. 1995, 67, 1617.
39. (c) Alonso de Velasco, E.; Verheul, A. F. M.; van Steijn, A. M. P.; Dekker, H. A. T.; Feldman, R. G.; Fernández, I. M.; Kamerling, J. P.; Vliegenthart, J. F. G.; Verhoef, J.; Snippe, H. Infect. Immun. 1994, 62, 799.
40. (d) Roberts, J. A.; Kaack, M. B.; Baskin, G.; Svenson, S. B. Infect. Immun. 1993, 61, 5214.
41. (e) Peeters, C. C. A. M.; Evenberg, D.; Hoogerhout, P.; Käyhty, H.; Saarinen, L.; van Boeckel, C. A. A.; van der Marel, G. A.; van Boom, J. H.; Poolman, J. T. Infect. Immun. 1992, 60, 1826.
42. Paulsen, H. Angew. Chem., Int. Ed. Engl. 1982, 21, 155.
43. (a) Pozsgay, V. J. Am. Chem. Soc. 1995, 117, 6673.
44. (b) Pozsgay, V.; Coxon, B. Carbohydr. Res. 1995, 277, 171.
45. (c) Pozsgay, V.; Pannell, L. Carbohydr. Res. 1994, 258, 105.
46. (d) Pozsgay, V.; Coxon, B. Carbohydr. Res. 1994, 257, 189.
47. (e) Pozsgay, V.; Coxon, B.; Yeh, H. Bioorg. Med. Chem. 1993, 1, 237.
48. (f) Pozsgay, V.; Glaudemans, C. P. J.; Robbing, J. B.; Schneerson, R. Carbohydr. Res. 1993, 244, 259.
49. (g) Pozsgay, V.; Glaudemans, C. P. J.; Robbins, J. B.; Schneerson, R. Tetrahedron 1992, 48, 10249.
50. (h) Pozsgay, V. Carbohydr. Res. 1992, 235, 295.
51. For recent reviews on thioglycoside synthesis, see: (a) Garegg, P. J. Adv. Carbohydr. Chem. Biochem. 1997, 52, 179.
52. (b) Norberg, T. Modern methods in carbohydrate synthesis; Khan, S. H., O'Neill, R. A., Eds.; Harwood Academic Publishers: 1996; p 82.
53. Yan, L.; Kahne, D. J. Am. Chem. Soc. 1996, 118, 9239.
54. Schmidt, R. R.; Kinzy, W. Adv. Carbohydr. Chem. Biochem. 1994, 50, 21.
55. Pozsgay, V.; Jennings, H. J. Synthesis 1990, 724.
56. Pozsgay, V.; Jennings, H. J. J. Org. Chem. 1988, 53, 4042.
57. Pavliak, V.; Kovac, P. Carbohydr. Res. 1991, 210, 333.
58. (a) Cook, A. F.; Maichuk, D. T. J. Org. Chem. 1970, 35, 1940.
59. (b) Bertolini, M. J.; Glaudemans, C. P. J. Carbohydr. Res. 1970, 15, 263.
60. (c) van Boeckel, C. A. A.; Beetz, T. Tetrahedron Lett. 1983, 24, 3775.
61. (d) Udodong, U. E.; Rao, C. S.; Fraser-Reid, B. Tetrahedron 1992, 48, 4713.
62. Lönn, H. Carbohydr. Res. 1985, 139, 105.
63. In one unpublished approach, an eicosasaccharide was prepared by linear condensation of five repeating units that contained an azido function at C-2 of the glucose unit. Numerous attempts to convert the azido to acetamido groups in that protected saccharide proved to be abortive.
64. Scriven, E. F. V.; Turnbull, K. Chem. Rev. 1988, 88, 298.
65. (a) Ellervik, U.; Magnusson, G. Carbohydr. Res. 1996, 280, 251.
66. (b) Pozsgay, V. In Carbohydrates, Synthetic Methods and Applications in Medicinal Chemistry; Ogura, H., Hasegawa, A., Suami, T., Eds.; Kodansha-Verlag Chemie: Tokyo-Weinheim, 1992; p 188.
67. (c) Paulsen, H.; Krogmann, C.; Liebigs Ann. Chem. 1989, 1203.
68. (d) Imoto, M.; Yoshimura, H.; Shimamoto, T.; Sakaguchi, N.; Shiba, T. Bull. Chem. Soc. Jpn. 1987, 60, 2205.
69. (e) Windholz, T. B.; Johnston, D. B. R. Tetrahedron Let. 1967, 2555.
70. Oikawa, Y.; Yoshioko, T.; Yonemitsu, O. Tetrahedron Lett. 1982, 23, 885.
71. Konradsson, P.; Udodong, U. E.; Fraser-Reid, B. Tetrahedron Lett. 1990, 31, 4313.
72. Veeneman, G. H.; van Leeuwen, S. H.; van Boom, J. H. Tetrahedron Lett. 1990, 31, 1331.
73. Sabesan, S.; Paulson, J. C. J. Am. Chem. Soc. 1986, 108, 2068.
74. Johannson, R.; Samuelsson, B. J. Chem. Soc., Perkin Trans. 1 1984, 2371.
75. Hancock, G.; Galpin, I. J.; Morgan, B. A. Tetrahedron Lett. 1982, 23, 249.
76. For a recent review, see: Lee, R. T.; Lee, Y. C. Glycosciences, Status and perspectives; Gabius, H.-J., Gabius, S., Eds.; Chapman & Hall: 1997; p 56.
77. Gray, G. R. Arch. Biochem. Biophys. 1974, 163, 426.
78. Lee, R. T.; Wong, T.-C.; Lee, R.; Yue, L.; Lee, Y. C. Biochemistry 1989, 28, 1856.
79. Other approaches to ω-aldehydoalkyl glycosides include (a) ozonolysis of O-allyl glycosides (Bernstein, M. E.; Hall, L. D. Carbohydr. Res. 1980, 78, C1).
80. (b) Swern oxidation of ω-hydroxyalkyl glycosides (Pozsgay, V. Glycoconj. J. 1993, 10, 133).
81. (c) use of ω-dioxolane-type aglycons (Palomimo, J. C. C.; Rensoli, M. H.; Verez-Bencomo, V. J. Carbohydr. Chem. 1996 15, 137).
82. (d) Use of a secondary spacer that features a protected aldehydo moiety (ref 53).
83. Mancuso, A. J.; Huang, S. L.; Swern, D. J. Org. Chem. 1978, 43, 2480.
84. A related aldehydo-acid having one less carbon has been reported: Nakamura, Y.; Ito, A.; Shin, C. Bull. Chem. Soc. Jpn. 1994, 67, 2151.
85. Dubois, M.; Gilles, K. A.; Hamilton, J. K.; Rebers, P. A.; Smith, F. Anal. Chem. 1956, 28, 350.
86. Characterization of the saccharide-protein conjugates by MALDI-TOF mass spectrometry avoids the errors of the traditionally used colorimetric procedures for saccharide determination that may reach 50%: Dambra, A. J.; Baugher, J. E.; Concannon, P. E.; Pon, R. A.; Michon, F. Anal. Biochem. 1997, 250, 228.
87. Pozsgay, V.; Dubois, E. P.; Pannell, L. J. Org. Chem. 1997, 62, 2832.
88. (a) Carter, D. C.; Ho, J. X. Adv. Protein Chem. 1994, 45, 153.
89. (b) Peters, D. T., Jr. Adv. Clin. Chem. 1970, 13, 37.
90. Patent application has been filed: Pozsgay, V.; Robbins, J. B.; Schneerson, R. Fed. Reg. 1998, 63, 1117.